Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Headache and vision loss in a middle-aged women.

Literature DB >> 31218546

Headache and vision loss in a middle-aged women.

Yue Lu¹, Jiasi Li², Xiaoying Bi³.

Abstract

Entities: Disease Species

Mesh：

Substances：
Janus Kinase 2

Year: 2019 PMID： 31218546 DOI： 10.1007/s10072-019-03958-5

Source DB: PubMed Journal: Neurol Sci ISSN： 1590-1874 Impact factor: 3.307

Keyword Cloud
References

× No keyword cloud information.

6 in total

1. Ischemic stroke with essential thrombocythemia: a case series.

Authors: Yuji Kato; Takeshi Hayashi; Yoshihide Sehara; Ichiro Deguchi; Takuya Fukuoka; Hajime Maruyama; Yohsuke Horiuchi; Yuito Nagamine; Hiroyasu Sano; Norio Tanahashi
Journal: J Stroke Cerebrovasc Dis Date: 2015-02-25 Impact factor: 2.136

2. Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.

Authors: Peter J Campbell; Linda M Scott; Georgina Buck; Keith Wheatley; Clare L East; Joanne T Marsden; Audrey Duffy; Elaine M Boyd; Anthony J Bench; Mike A Scott; George S Vassiliou; Donald W Milligan; Steve R Smith; Wendy N Erber; David Bareford; Bridget S Wilkins; John T Reilly; Claire N Harrison; Anthony R Green
Journal: Lancet Date: 2005-12-03 Impact factor: 79.321

Review 6. JAK2(V617F) positive early stage myeloproliferative disease (essential thrombocythemia) as the cause of portal vein thrombosis in two middle-aged women: therapeutic implications in view of the literature.

Authors: J J Michiels; S Commandeur; G J Hoogenboom; J J Wegman; L Scholten; R H van Rijssel; H De Raeve
Journal: Ann Hematol Date: 2007-08-09 Impact factor: 3.673

6 in total

Headache and vision loss in a middle-aged women.

1. Ischemic stroke with essential thrombocythemia: a case series.

2. Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.

Review 3. JAK2 V617F in myeloid disorders: what do we know now, and where are we headed?

4. Clinical reasoning: a 24-year-old woman with progressive headache and somnolence.

Review 5. Evolving Treatments for Arterial and Venous Thrombosis: Role of the Direct Oral Anticoagulants.

Review 6. JAK2(V617F) positive early stage myeloproliferative disease (essential thrombocythemia) as the cause of portal vein thrombosis in two middle-aged women: therapeutic implications in view of the literature.